The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.60% to $484.82 Monday, on what proved to be an all-around favorable ...

Vertex Pharmaceuticals (VRTX) closed at $502.55 in the latest trading session, marking a +0.45% move from the prior day. Recently, Zacks.com users have been paying close attention to Vertex (VRTX).

In recent trading, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) have crossed above the average analyst 12-month target price of $505.52, changing hands for $513.76/share. When a stock ...

This period of growth follows what Pirnat called “20 straight months of down.” Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) and Boston Scientific Corp. were among the large, local companies to ...

Vertex Pharmaceuticals Inc. closed 5.23% below its 52-week high of $519.88, which the company achieved on November 8th.